SCOTT BASS heads the firm’s Global Life Sciences Team, coordinating pharmaceutical, medical device, food and dietary supplement matters in the United States, Europe and Asia. He is ranked internationally among the top authorities on FDA-related enforcement and regulatory issues, and has led audits and investigations involving off-label promotion, pharmacovigilance, PDMA, GMP, and fraud and abuse issues, as well as DEA and FTC matters. Mr. Bass served as an adjunct professor at Georgetown University Graduate School, as Co-Chair of the ABA Food and Drug Law Committee, Chairman of the N.Y. State Bar Association Section on Food, Drug and Cosmetic Law, as an expert in an EU Commission study, and as an advisor on new China drug and device legislation. Mr. Bass has published many articles and books in the pharmaceutical, enforcement and dietary supplement and functional foods fields.
Recent awards and recognitions:
- "The cream of the crop" for FDA enforcement and regulatory issues in Who's Who Legal;
- Three times named to the BTI Client Service All-Star Team (2009, 2007, 2005), based upon interviews with Fortune 1000 companies; One of the top five U.S. lawyers recognized as “MVP: Truly Outstanding” on the BTI Client Service All-Star Team in 2007;
- Only Life Sciences lawyer with Leading ranking in both the “Government Enforcement and Investigation“ and “Regulatory“ categories in PLC's 2009/10, 2008/09, and 2007/08 surveys of leading Life Sciences lawyers worldwide; and
- Named by Washingtonian Magazine as one of the “Top FDA Lawyers in Washington“ in 2009 and 2008.
